Dopamine D3 receptor antisense reduces neuropeptide mRNA levels in rat nucleus accumbens

NeuroReport

Volumn 8, Issue 18, 1997, Pages 3901-3905

  Tremblay, Martine ^a   Rouillard, Claude ^a   Lévesque, Daniel ^a  

^a NONE

Author keywords

Antisense oligonucleotide; Dopamine D3 receptor; Dynorphin; In situ hybridization; Neuroleptic; Neurotensin; Nucleus accumbens core; Nucleus accumbens shell; Radioreceptor assay; Rat

Indexed keywords

DOPAMINE 3 RECEPTOR; DYNORPHIN; MESSENGER RNA; ANTISENSE OLIGONUCLEOTIDE; DOPAMINE 2 RECEPTOR; DRD3 PROTEIN, RAT; NEUROTENSIN;

ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; CENTRAL NERVOUS SYSTEM; DRUG EFFECT; DRUG RECEPTOR BINDING; GENE EXPRESSION REGULATION; GENETIC REGULATION; IN SITU HYBRIDIZATION; LATERAL BRAIN VENTRICLE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; ANIMAL; GENETICS; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; METABOLISM; PHYSIOLOGY; REPRODUCIBILITY; SPRAGUE DAWLEY RAT;

ANIMALS; DYNORPHINS; GENE EXPRESSION REGULATION; INJECTIONS, INTRAVENTRICULAR; MALE; NEUROTENSIN; NUCLEUS ACCUMBENS; OLIGONUCLEOTIDES, ANTISENSE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; REPRODUCIBILITY OF RESULTS; RNA, MESSENGER;

EID: 0031583774     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199712220-00012     Document Type: Article

References (24)

1. Sokoloff P, Giros B, Martres MP et al. Nature 347, 146-151 (1990).
2. Lévesque D, Diaz J, Pilon C et al. Proc Natl Acad Sci USA 89, 8155-8159 (1992).
3. Diaz J, Lévesque D, Lammers CH et al. Neurosci 65, 731-745 (1995).
4. Merchant KM and Dorsa DM. Proc Natl Acad Sci USA 90, 3447-3451 (1993).
5. Lévesque D, Martres M-P, Diaz J et al. Proc Natl Acad Sci USA 92, 1719-1723 (1995).
6. Zahm DS and Brog JS. Neuroscience 50, 751-767 (1992).
7. Diaz J, Lévesque D, Griffon N et al. Eur J Neurosci 6, 1384-1387 (1994).
8. Nissbrandt H, Ekman A, Eriksson E et al. Neuroreport 6, 573-576 (1995).
9. Tepper JM, Sun BC, Martin LP et al. J Neurosci 17, 2519-2530 (1997).
10. Weiss B, Zhang S-P and Zhou L-W. Life Sci 60, 433-455 (1997).
11. Lévesque D. Biochem Pharmacol 52, 511-518 (1996).
12. Morissette M, Lévesque D and Di Paolo T. Mol Pharmacol 42, 480-488 (1992).
13. Kislauslis E, Bullock B, McNeil S et al. J Biol Chem 263, 4963-4968 (1988).
14. Civelli O, Douglass J, Goldstein A et al. Proc Natl Acad Sci USA 82, 4291-4295 (1985).
15. Curran EJ and Watson SJ Jr. J Comp Neurol 361, 57-76 (1995).
16. Gerfen CR, Engber TM, Mahan LC et al. Science 250, 1429-1432 (1990).
17. Fox CA, Mansour A and Watson SJ Jr. Exp Neurol 130, 288-303 (1994).
18. Lynch MR and Ormsby JL. NeuroReport 8, 611-615 (1997).
19. Bordet R, Ridray S, Carboni S et al. Proc Natl Acad Sci USA 94, 3363-3367 (1997).
20. Zhang M, Tarazi F and Creese I. Soc Neurosci Abstr 20, 909 (1994).
21. Accili D, Fishburn CS, Drago J et al. Proc Natl Acad Sci USA 93, 1945-1949 (1996).
22. Whitesell L, Geselowitz D, Chavany C et al. Proc Natl Acad Sci USA 90, 4665-4669 (1993).
23. Zhang S-P, Zhou L-W. Morabito M et al. J Mol Neurosci 7, 13-28 (1996).
24. Qin Z-H, Zhou L-W, Zhang SP et al. Mol Pharmacol 48, 730-737 (1995).